Sign for Notice Everyday    Sign Up| Sign In| Link|

Our Sponsors

  • ESTA - Electronic System for Travel Authorization
Receive Latest News

Feedburner
Share Us

Live Webinar New and Expected Guidances on Data Standards and Electronic Submissions for Drugs and Medical Products

View: 38

Website https://worldcomplianceseminars.com/webinardetails/417 | Edit Freely

Category

Deadline: May 24, 2018 | Date: May 24, 2018

Venue/Country: Online, U.S.A

Updated: 2018-05-08 16:36:18 (GMT+9)

Call For Papers - CFP

Live Webinar New and Expected Guidances on Data Standards and Electronic Submissions for Drugs and Medical Products

Time: 01:00 PM EDT | 10:00 AM PDT | 12:00 PM CDT Duration 90 Minutes

Description

Each FDA center has different guidelines and processes to follow in order to have a successful submission for the regulatory review of the medical product. The submission process for drugs, biologics and medical devices is rigorous and has specific timelines and standards to follow.

The agencies (FDA, EMEA) encourage electronic submissions and they have developed data standards and other guidelines. The Common Technical Document (CTD) describes the modules, sections and documents to be used by an Applicant for a Marketing Authorization for a medical product for human use ( EU, Japan and US). Different Standard Development Organizations (HL7, ISO, CDISC, ICH) work to produce and harmonize standards nationally and worldwide to improve regulatory submissions.

Why should you attend

This webinar will provide the new and expected guidances on data standards and electronic submissions for drugs and medical products. We will explain what are the policies and the requirements for submissions and standards for drugs in US and globally and how it affects healthcare/drug industry to adopt them.

All functional groups and professionals who have responsibility in the submissions and approval process for medical products and need to have an overview of the field should attend

Areas Covered

• Quality & Product Data Standards

• Study Data Standards Update

• Approval Process for Drugs, Biologics and Devices

• Submission Requirements & Guidances, FDA

• Electronic Regulatory Submission & Gateway, FDA

• e-Submissions, EMEA, EU and globally

• International Conference on Harmonization (ICH)

• Electronic Common Technical Document (eCTD), ICH

• eCTD Guidance and Specifications, FDA

• Health Level 7 Regulated Clinical Research Information Management

• Clinical Data Interchange Standards Consortium, (SDTM, SEND, ADAM)

• Biomedical Research Integrated Domain Group (NIH, FDA, CDISC, HL7)

• Top 10 Issues with Data

Who will Benefit

• Management (Pharma, Biotech)

• Policy analysts

• Government officers

• Health IT Managers and Analysts

• Research and Development (Pharmaceutical, Academia)

• Regulatory Affairs personnel

• Quality assurance/quality control personnel

Speaker Profile

Angela Bazigos.CEO of Touchstone Technologies Inc. She has 40 years of experience in the Life Sciences & Healthcare Industries. Experience combines Quality Assurance, Regulatory Compliance, Business Administration, Information Technology, Project Management, Clinical Lab Science, Microbiology, Food Safety, Turnarounds and Business Development. Past employers / clients include Roche, Novartis, Genentech & PriceWaterhouseCoopers. Positions include Chief Compliance Officer at Morf Media. Co-authored & prototyped 21 CFR 11 guidance with FDA. Co-authored Computerized Systems in Clinical Research w/ FDA.

Price: $179 One Dial-in One Attendee | Corporate Live Recorded $279 One Dial In - Max 10 attendees |Group $695 Multiple locations upto 5 dial in | Recorded $249


Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.